Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Quantum Computing Providing-of-gases-for-an-excimer-laser

 Hydrated biodegradable superparamagnetic metal oxides
OF THE INVENTION 1. Preparation of Coated Superparamagnetic Iron Oxide Particles The synthesis of ...


 Halide-free process for the synthesis of ETS-10
OF THE INVENTION The present invention is directed towards crystalline titanium molecular sieve ...


 Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
OF THE INVENTION Compounds of the present invention can be made according to the schematic ...


 Macrocyclic polyamines
OF THE INVENTION Macrocyclic polyamines which form stable complexes with metal ions are known. The ...


 Fishing lure retriever
The embodiments of the invention in which an exclusive property or privilege is claimed are defined ...


 Magnetic resonance imaging agents
OF THE INVENTION The complexing agents employed in this invention are derivatives of well-known ...


 Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor
We claim: 1. A method for detecting and locating any inflammatory and/or tumor foci in a patient ...


 Extended lifetime railgap switch
I claim: 1. In a railgap switch of the type having an elongate blade electrode made of conductive ...


 Interhalogen based combustion-driven laser which provides continuous wave output lasing from dual species
Having thus described typical embodiments of my invention, that which I claim as new and desire to ...


 Data transmission system
Accordingly, the present invention has been devised with a view to substantially eliminating the ...


 Providing of gases for an excimer laser

Details
Inventors: Turner, Robert;
Assignee:
Primary Examiner: Scott, Jr.; Leon
Assistant Examiner:
Attorney, Agent or Firm: Roberts, Spiecens & Cohen

A method of reducing an expenditure of a rare gas in an excimer laser system includes evacuating a lasing material including a mixture of diluent rare gas and removing therefrom halogen compounds. Supplemental lasing material is then added to the lasing mixture.

DETAILED DESCRIPTION In FIG.
1 the closed-cycle excimer laser system centers around the excimer laser 10.
The excimer laser 10 is a conventional design and in its lasing chamber has a gas mixture of a halogen, a heavy rare gas and a diluent rare gas.
A typical lasing gas mixture would be a halogen gas such as flourine or gaseous hydrogen chloride in concentrations of 10ths of a percent, a heavy rare gas such as argon, krypton or xenon in concentrations of the order of 2 to 5 percent and a diluent range gas such as helium and/or neon in concentrations in the order of 95 percent.
Because of the lasing action, there are formed gaseous and particulate compounds which if not removed from the laser will eventually reduce the efficiency of operation and finally quench any possible lasing action.
Therefore, in accordance with the invention, the lasing mixture is exhausted or removed from the excimer laser 10 and passed through the cleanup means 12.
In the cleanup means 12 the halogen compounds are removed from the gas mixture so that at the output of the cleanup means 12 there is a pure gas mixture of the heavy rare gas and the diluent rare gas.
The cleaned gas mixture is fed via a check valve 16 back to the excimer laser 10.
Since the halogen has been removed it is now necessary to replenish the gas mixture with the halogen gas.
Accordingly, there is also fed into the input of the laser 10 a supplement gas mixture from the source 18.
This gas mixture includes the halogen, the heavy rare gas and the diluent rare gas in percentages related to the original gas mixture.
In particular, the halogen in the supplemental gas mixture is substantially greater in concentration than the original concentration.
In particular, its percentage is at least one order of magnitude greater and typically 50 times greater.
Thus, it is not unusual for the supplemental gas mixture to be in the order of 10 percent halogen.
The remainder of the supplemental gas mixture is a combination of the heavy rare gas and the diluent rare gas



Related patents
  Compact and highly efficient laser pump cavity
To resolve these issues, an aspect of the present invention uses a new side-pumped scheme with a novel pump cavity configuration that improves laser performance. A...
  Automatic in-feed conveyor system for an ice injector system
We claim: 1. An automatic in-feed system for use with an ice injector comprising: an in-feed conveyor for simultaneously receiving a plurality of on-loaded pallets ...
  Gamma emitting, CCK-A antagonists for pancreatic imaging
OF THE INVENTION The present invention is directed toward radiolabelled compounds of Formula I: ##STR2## wherein: A is ##STR3## R.sup.1 is H, C.sub.1 -C.sub.6 linear or ...
  Optical amplifying device
FIG. 2 illustrates one embodiment of an amplifying device 10 wherein the laser device 110 is surface emitting with a number of active regions forming a "total active ...
  Pharmaceutical delivery system
The present invention provides a method and means for dispensing in a controlled, continuous manner therapeutically effective amounts of water-soluble drugs for a ...
  Nitrogen-containing cyclic ligands
We claim: 1. A ligand having the formula: ##STR44## in which R.sub.1 represents a radical of the formula: ##STR45## R.sub.6 being selected from the group consisting of C....
  Conditioning shampoo
OF THE PREFERRED EMBODIMENT The conditioning shampoo composition of the preferred embodiment includes the following ingredients in the ranges, preferred ranges and best ...
  Methods of diagnostic image analysis using lipophilic contrast agents
OF THE INVENTION The present invention is directed to complexing acids and salts thereof which when combined with a paramagnetic, ferromagnetic or diamagnetic metal ion ...
  Method for increasing sensitivity to chemically induced terminal differentiation
OF THE INVENTION The present invention provides a method of selectively inducing terminal differentiation of neoplastic cells and thereby inhibiting proliferation of ...
  Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
What is claimed is: 1. In a method for enhancing safety in the in vivo use of methal-ligand chelate complexes as magnetic resonance imaging agents comprising ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved